Teledermatology Enables Earlier Diagnosis of Cutaneous Squamous Cell Carcinoma
Project Oncology®Teledermatology Enables Earlier Diagnosis of Cutaneous Squamous Cell Carcinoma
Smoking Status Predicts Worse Survival in Non-Melanoma Skin Cancer
Project Oncology®Smoking Status Predicts Worse Survival in Non-Melanoma Skin Cancer
Early Onset of Response to Zasocitinib (TAK-279), a Highly Selective and Potent TYK2 Inhibitor, Is Correlated With Modulation of TYK2 Signaling and Disease Pathway Biomarkers in Patients With Moderate-to-Severe Plaque Psoriasis
DermatologyEarly Onset of Response to Zasocitinib (TAK-279), a Highly Selective and Potent TYK2 Inhibitor, Is Correlated With Modulation of TYK2 Signaling and Disease Pathway Biomarkers in Patients With Moderate-to-Severe Plaque Psoriasis
Once-Daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002)
DermatologyOnce-Daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002)
Unpacking the Complexity of Psoriatic Arthritis
Living RheumUnpacking the Complexity of Psoriatic Arthritis
Diagnosing Psoriatic Arthritis: A Real-World Case
Living RheumDiagnosing Psoriatic Arthritis: A Real-World Case
- advertisement
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
CME/CEStuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
CME/CENavigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
CME/CETargeting CKD-aP at the Source: Key Mechanisms and Treatments
Test Your Skills and Learn From Experts on Best Practice in Diagnosis and Management of Systemic Mastocytosis
CME/CETest Your Skills and Learn From Experts on Best Practice in Diagnosis and Management of Systemic Mastocytosis
Hitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease
CME/CEHitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease
When Topicals Fail: The New IPC Consensus Every Clinician Should Know
CME/CEWhen Topicals Fail: The New IPC Consensus Every Clinician Should Know
- advertisement
Living with Psoriatic Arthritis: A Doctor-Patient Conversation
Medical Industry FeatureLiving with Psoriatic Arthritis: A Doctor-Patient Conversation
Understanding Dual Inhibition of IL-17
Medical Industry FeatureUnderstanding Dual Inhibition of IL-17
- 04/09/2026
- 04/08/2026
- 04/01/2026
- 03/24/2026
- 03/18/2026
- 03/16/2026